Parkinson's Disease Expertise

Parkinson's disease, a progressive neurodegenerative disorder that disrupts movement and balance, affects millions worldwide. At Southern Research, we are dedicated to providing comprehensive preclinical Parkinson's disease services, empowering researchers like you to unravel the complexities of this disease and pave the way for groundbreaking therapies.


Combating Parkinson's Disease

Your Partner in Preclinical Parkinson's Disease Research and Testing

Our team of seasoned neuroscientists, neurologists, and molecular biologists possesses extensive experience in understanding the pathogenesis, progression, and potential therapeutic targets of Parkinson’s disease. We are well-versed in a variety of in vitro and in vivo Parkinson’s disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutic compounds and cellular therapies.

Comprehensive Services Spanning the Parkinson’s Disease Spectrum

We offer a comprehensive suite of preclinical Parkinson’s disease services tailored to address the diverse challenges posed by this disease:

Neuroprotective and Disease-Modifying Compound Screening and Optimization: We utilize a range of in vitro and in vivo screening assays to identify promising neuroprotective and disease-modifying compounds, optimizing their potency, selectivity, and safety profile.

Pharmacokinetic and Pharmacodynamic (PK/PD) Studies: We determine the absorption, distribution, metabolism, and excretion (ADME) properties of potential therapeutic compounds, providing valuable insights into their pharmacokinetic profiles and pharmacodynamic effects in the central nervous system (CNS).

Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.


The Power of Collaboration

Accelerating the Pace of Parkinson's Disease Research

By partnering with Southern Research, you gain access to a wealth of expertise, resources, and infrastructure, enabling you to focus on your core competencies while we handle the complexities of preclinical Parkinson’s disease research and testing. This strategic alliance empowers you to:

  • Accelerate your research timelines and bring potential therapies closer to patients
  • Enhance the efficiency and productivity of your research efforts
  • Optimize resource allocation and cost-effectiveness through access to specialized expertise and infrastructure
  • Ensure adherence to stringent regulatory standards and facilitate a smooth transition to clinical trials
  • Mitigate the risk of project delays or failures through our rigorous preclinical testing and development process

Restoring Movement and Hope in Parkinson’s Disease Together

Contact us today to discuss your preclinical Parkinson’s disease research and testing needs, and let us help you pave the way for a future free from this debilitating disorder.

Basic Template Image